<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1303233356
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2012
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        RINGERS LACTATE SOLU. FOR I.V. INFUSION IN VIAFLEX
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        SODIUM CHLORIDE,SODIUM LACTATE,POTASSIUM CHLORIDE, CALCIUM CHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        6,3.22,0.4,0.27
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        g/l
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for infusion
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        500
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bag
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        6.85
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="BAXTER CO LIMITED" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            BAXTER CO LIMITED
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 613]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            BAXTER CO LIMITED
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Baxter Company Limited
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        B05BB01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Ringer&rsquo;s Lactate Infusion is a solution of the following substances in water:<br />- sodium chloride<br />- potassium chloride<br />- calcium chloride dihydrate<br />- sodium lactate.<br />Sodium, potassium, calcium, chloride and lactate are chemical substances (electrolytes) found in the blood.<br />Ringer&rsquo;s Lactate Infusion is used:<br />- to treat a loss of body water and chemicals (e.g. by heavy sweating, kidney disorders)<br />- to treat you, if the volume of blood in your blood vessels is low (hypovolaemia) or if you have low blood pressure (hypotension)<br />- in metabolic acidosis (when the blood becomes too acidic).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>You must NOT receive Ringer&rsquo;s Lactate Infusion if you are suffering from any of the following conditions<br />- if you&rsquo;re a newborn (less than 28 days old) receiving ceftriaxone (an antibiotic)<br />- if you&rsquo;re allergic to sodium lactate or any of the other ingredients in Ringer&rsquo;s Lactate (listed in section 6)<br />- when there is too much fluid in the spaces around the cells of the body (extracellular hyperhydration)<br />- when there is a larger volume of blood in the blood vessels than there should be (hypervolaemia)<br />- severe kidney failure (when your kidneys do not work well and you require dialysis)<br />- uncompensated heart failure. This is heart failure that is not adequately treated and causes symptoms such as:<br />- shortness of breath<br />- swelling of the ankles<br />- higher levels of potassium in the blood than normal (hyperkalaemia)<br />- higher levels of calcium in the blood than normal (hypercalcaemia)<br />- a disorder in which the blood becomes too alkaline (metabolic alkalosis)<br />- liver disease that causes fluid to build up within the abdomen (ascitic cirrhosis)</p><p>- your blood is too acidic which is life-threatening (severe metabolic acidosis)<br />- a particular type of metabolic acidosis (lactic acidosis)<br />- severe liver disease (when the liver does not function properly and requires very intensive treatment)<br />- poor lactate metabolism (this occurs in severe liver disease, as lactate is removed by the liver)<br />- if you are taking cardiac glycosides (cardiotonics) used to treat heart failure, such as digitalis or digoxin (see also &ldquo;Taking other medicines&rdquo;).</p><p><strong>Warning and precautions</strong><br />Talk to your doctor or nurse before receiving Ringer&rsquo;s Lactate Infusion if you have or have had any of the following medical conditions:<br />- if you&rsquo;re receiving ceftriaxone (an antibiotic) (see also &ldquo;Other medicines and Ringer&rsquo;s Lactate Infusion&rdquo;)<br />- heart failure<br />- respiratory failure (lung disease) (special monitoring may be required in the above conditions)<br />- poor kidney function<br />- higher levels of chloride in the blood than normal (hyperchloraemia)<br />- high blood pressure (hypertension)<br />- build up of fluid under the skin, affecting all parts of the body (general oedema)<br />- build up of fluid under the skin, particularly around the ankles (peripheral oedema)<br />- build up of fluid in the lungs (pulmonary oedema)<br />- high blood pressure during pregnancy (pre-eclampsia)<br />- a disease that causes high levels of a hormone called aldosterone (aldosteronism)<br />- higher levels of sodium in the blood than normal (hypernatraemia) or any other condition associated with sodium retention (when the body retains too much sodium), such as treatment with steroids (See also below, &ldquo;Taking other medicines&rdquo;)<br />- heart disease of any type<br />- any condition that means that you are more likely to have high blood levels of potassium (hyperkalaemia), such as:</p><p>- kidney failure<br />- adrenocortical insufficiency (this disease of the adrenal gland affects hormones that control the concentration of chemicals in the body)<br />- acute dehydration (a loss of water from the body, e.g. due to vomiting or diarrhoea)<br />- extensive tissue damage (as can occur in severe burns)<br />Close monitoring of your blood potassium levels is required.<br />- diseases associated with high levels of vitamin D (e.g. sarcoidosis, a disease affecting the skin and internal organs)<br />- kidney stones<br />- poor liver function<br />- diabetes if you have a condition that could cause high levels of vasopressin, a hormone regulating fluid in your body. You may have too much vasopressin in your body because, for example:<br />- you have had a sudden and serious illness<br />- you are in pain<br />- you have had surgery<br />- you have infections, burns or brain disease<br />- you have diseases linked to your heart, liver, kidneys or central nervous system<br />- because you are taking certain medicines (see also below Other medicines and &lsquo;Ringer&rsquo;s Lactate Infusion&rsquo;).</p><p>This may increase the risk of low levels of sodium in your blood and can lead to headache, nausea, seizures, lethargy, coma, swelling of the brain and death. Brain swelling increases the risk of death and brain damage. People who are at higher risk of brain swelling are:<br />- children<br />- women (particularly if you are of a fertile age)<br />- people who have problems with their brain fluid levels, for example, because of meningitis, bleeding in the skull or a brain injury.<br />When you are given this infusion, your doctor will take blood and urine samples to monitor:<br />- the amount of fluid in your body</p><p>- the amount of chemicals such as sodium and potassium in your blood (your plasma electrolytesthe acidity of your blood and urine (your acid-base balance).<br />Although Ringer&rsquo;s Lactate Infusion contains potassium, it does not contain enough to treat very low blood plasma levels of potassium (severe potassium deficiency).<br />Calcium chloride can be harmful if injected into the body tissues. Therefore, the Ringer&rsquo;s Lactate Infusion must not be given by injecting it into a muscle (intramuscular injection). Also, your doctor will make every effort to avoid the escape of the solution into the tissues surrounding the vein.<br />Ringer&rsquo;s Lactate Infusion must not be given through the same needle as a blood transfusion. This can damage the red blood cells or cause them to clump together.<br />As Ringer&rsquo;s Lactate Infusion contains lactate (a substance found in the body), it can make your blood too alkaline (metabolic alkalosis).<br />Ringer&rsquo;s Lactate Infusion should be given with special care to babies less than 6 months of age.<br />Your doctor will take into account if you are receiving parenteral nutrition (nutrition given by infusion into a vein). If you are given Ringer&rsquo;sLactate Infusion for a long time, you will be given an extra source of nutrients.</p><p><strong>Other medicines and Ringer&rsquo;s Lactate Infusion</strong><br />Tell your doctor or nurse if you are taking, have recently taken or might take any other medicines.<br />It is particularly important that you inform your doctor if you are taking:<br />- ceftriaxone (an antibiotic), this should not be given through the same infusion line, unless thoroughly flushed.<br />- cardiac glycosides (cardiotonics) such as digitalis or digoxin used to treat heart failure, must not be used with Ringer&rsquo;s Lactate Infusion (see also section &ldquo;You must NOT receive Ringer&rsquo;s Lactate Infusion if you are suffering from&hellip;&rdquo;). The effects of these drugs can be increased by calcium. This can lead to life threatening changes to the heart rhythm<br />- corticosteroids (anti-inflammatory medicines)<br />These medicines can cause the body to accumulate sodium and water, leading to:<br />- tissue swelling due to fluid collection under the skin (oedema)<br />- high blood pressure (hypertension).</p><p>The following medicines can increase the concentration of potassium in the blood. This effect can be life-threatening. A rise in the blood potassium levels is more likely to occur if you have kidney disease.<br />- potassium-sparing diuretics (certain water tablets, e.g. amiloride, spironolactone, triamterene)<br />(Note that these medicines may be included in combination medicinal products)<br />- angiotensin converting enzyme (ACE) inhibitors (used to treat high blood pressure)<br />- angiotensin II receptor antagonists (used to treat high blood pressure)<br />- tacrolimus (used to prevent rejection of a transplant and to treat some skin diseases)<br />- cyclosporin (used to prevent rejection of a transplant).<br />Some medicines act on the hormone vasopressin. These may include:<br />- anti-diabetic medication (chlorpropamide)<br />- cholesterol medicine (clofibrate)<br />- some cancer drugs (vincristine, ifosfamide, cyclophosphamide)<br />- selective serotonin reuptake inhibitors (used to treat depression)<br />- antipsychotics<br />- opioids for severe pain relief<br />- medicines for pain and/or inflammation (also known as NSAIDs)<br />- medicines that imitate or strengthen the effects of vasopressin such as desmopressin (used to treat increased thirst and urination), terlipressin (used to treat bleeding of the gullet) and oxytocin (used to induce labour)<br />- anti-epileptic medication (carbamazepine and oxcarbazepine)</p><p>- diuretics (water tablets).<br />Other medicines that can affect or be affected by Ringer&rsquo;s Lactate Infusion include:<br />- thiazide diuretics such as hydrochlorothiazide or chlortalidone<br />- vitamin D<br />- bisphosphonates (to treat bone diseases such as osteoporosis)<br />- fluoride (for the teeth and bones)<br />- fluoroquinolones (a type of antibiotic, including ciprofloxacin, norfloxacin, ofloxacin)<br />- tetracyclines (a type of antibiotic, including tetracycline)<br />- acidic medicines, including:<br />- salicylates used to treat inflammation (aspirin)<br />- barbiturates (sleeping tablets)<br />- lithium (used to treat psychiatric illness)<br />- alkaline (basic) medicines including:<br />- sympathomimetics (stimulant medicines such as ephedrine and pseudoephedrine, used in cough and cold preparations)<br />- other stimulants (e.g. dexamphetamine, phenfluramine).</p><p><strong>Ringer&rsquo;s Lactate Infusion with food and drink</strong><br />You should ask your doctor about what you can eat or drink.<br /><strong>Pregnancy, breast-feeding and fertility</strong><br />If you are pregnant of breast feeding, think you may be pregnant or are planning to have a baby, ask your doctor or nurse for advice before taking this medicine. Ringer&rsquo;s Lactate Infusion can be used safely during pregnancy or breast-feeding. Your doctor will monitor the levels of chemicals in your blood and the amount of fluid in your body.<br />Calcium can reach your unborn baby through the placenta and, after birth, through the breast milk.<br />However, if another medicine is to be added to your solution for infusion during pregnancy or breast-feeding you should:<br />- consult your doctor<br />- read the Package Leaflet of the medicine that is to be added.<br /><strong>Driving and using machines</strong><br />Ask your doctor or pharmacist for advice before driving or using machines.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>You will be given Ringer&rsquo;s Lactate Infusion by a doctor or nurse. Your doctor will decide on how much you need and when it is to be given. This will depend on your age, weight, condition and the reason for treatment. The amount you are given may also be affected by other treatments you are receiving.<br />You should NOT be given Ringer&rsquo;s Lactate Infusion if there are particles floating in the solution or if the pack is damaged in any way.<br />Ringer&rsquo;s Lactate Infusion will usually be given to you through a plastic tube attached to a needle in a vein. Usually a vein in your arm is used to give you the infusion. However, your doctor may use another method to give you the medicine.<br />Before and during the infusion, your doctor will monitor:<br />- the amount of fluid in your body<br />- the acidity of your blood and urine<br />- the amount of electrolytes in your body (particularly sodium, in patients with high level of the vasopressin, or are taking other medicines which increase the effect of vasopressin).<br />Any unused solution should be thrown away. You should NOT be given an infusion of Ringer&rsquo;s Lactate Infusion from a bag that has been partly used.</p><p><strong>If you receive more Ringer&rsquo;s Lactate Infusion than you should</strong><br />If you are given too much Ringer&rsquo;s Lactate Infusion (over-infusion) or it is given too fast, this may lead to the following symptoms:<br />- water and/or sodium (salt) overload with build up of liquid in the tissues (oedema) causing swelling<br />- hyperkalaemia (higher levels of potassium in the blood than normal) especially in patients with kidney failure, causing symptoms such as:<br />- pins and needles in the arms and legs (paraesthesia)<br />- muscle weakness<br />- an inability to move (paralysis)<br />- an irregular heartbeat (cardiac arrhythmias)<br />- heart block (a very slow heartbeat)<br />- cardiac arrest (the heart stops beating; a life-threatening situation)<br />- confusion<br />- hypercalcaemia (higher levels of calcium in the blood than normal) causing symptoms such as:<br />- a decreased appetite (anorexia)<br />- feeling sick (nausea)<br />- vomiting<br />- constipation<br />- abdominal pain<br />- mental disturbances such as irritability or depression<br />- drinking lots of water (polydipsia)<br />- producing more urine than normal (polyuria)<br />- kidney disease due to build up of calcium in the kidneys (nephrocalcinosis)<br />- kidney stones</p><p>- coma (unconsciousness)<br />- chalky taste<br />- redness (hot flushes)<br />- dilatation of the blood vessels in the skin (peripheral vasodilatation).<br />- Hypokalaemia (lower levels of potassium in the blood than normal) and metabolic alkalosis (when the blood becomes too basic), especially in patients with kidney failure, causing symptoms such as:<br />- mood changes<br />- tiredness<br />- shortness of breath<br />- stiffness of the muscles<br />- twitching of the muscles<br />- contraction of muscles.<br />If you develop any of these symptoms you must inform your doctor immediately. Your infusion will be stopped and you will be given treatment depending on the symptoms.<br />If a medicine has been added to your Ringer&rsquo;s Lactate Infusion before over-infusion occurs, that medicine may also cause symptoms. You should read the Package Leaflet of the added medicine for a list of possible symptoms.<br />Stopping your Ringer&rsquo;s Lactate Infusion<br />Your doctor will decide when to stop giving you this infusion.<br />If you have any further questions on the use of this product, ask your doctor or nurse.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.<br />If you have any of the following symptoms you should tell your doctor or nurse immediately.</p><p>These may be signs of a very severe or even fatal hypersensitivity (allergic) reaction called anaphylactic shock:</p><ul><li>- hives (urticaria) which may be localised to a part of the body or widespread</li><li>- skin rash</li><li>- redness of the skin (erythema)</li><li>- itching (pruritus)</li><li>- skin swelling (angioedema)</li><li>- coughing</li><li>- narrowing of the airways causing difficulty breathing (bronchospasm)</li><li>- a fast heartbeat (tachycardia)</li><li>- a slow heartbeat (bradycardia)</li><li>- decreased blood pressure</li><li>- chest discomfort or pain</li><li>- anxiety</li><li>- tightness of the chest (making it difficult to breathe)</li><li>- shortness of breath (dyspnea)</li><li>- flushing</li><li>- throat irritation</li><li>- pins and needles (paraesthesia)</li><li>- reduced sense in the mouth (hypoesthesia oral)</li><li>- altered taste (dysgeusia)</li><li>- fever (pyrexia)</li><li>- nausea</li><li>- headache.</li></ul><p style="margin-left:.5in">Higher levels of potassium in the blood than normal (hyperkalaemia)<br />Low levels of sodium in the blood that may be acquired during hospitalization (nosocomial hyponatraemia) and related neurological disorder (acute hyponatraemic encephalopathy). Hyponatraemia can lead to irreversible brain injury and death due to cerebral oedema/swelling (see also in the section 2&ldquo;Warning and precautions&rdquo;).<br />Reactions due to the administration technique manifested by one or more of the following symptoms:<br />&bull; local pain or reaction redness or swelling at the site of infusion<br />&bull; irritation and inflammation of the vein into which the solution is infused (phlebitis). This can cause redness, pain or burning and swelling along the path of the vein into which the solution is infused.<br />&bull; rash or itching (pruritus) of the infusion site.<br />Other side effects noted with similar products (other sodium-lactate containing solutions) include:<br />- other manifestations of hypersensitivity/infusion reactions: a blocked nose (nasal congestion), sneezing, swelling in the throat making it difficult to breathe (laryngeal oedema also called Quincke&rsquo;s oedema), skin swelling (angioedema)<br />- changes in the concentrations of the chemicals in the blood (electrolyte disturbances)<br />- a larger volume of blood in the blood vessels than there should be (hypervolemia)<br />- panic attack<br />- other reactions due to the administration technique: infection at the site of infusion, escape of the infusion solution into the tissues around the vein (extravasation). This can damage the tissues and cause scarring, numbness at the site of infusion.</p><p style="margin-left:.5in">If a medicine has been added to the solution for infusion, the added medicine may also cause side effects. These side effects will depend on the medicine that has been added. You should read the Package Leaflet of the added medicine for a list of possible symptoms.<br />Reporting of side effects<br />If you get any side effect, talk to your doctor or nurse. This includes any possible side effect not listed in this<br />leaflet.You can also report side effects directly via the national reporting system listed below.</p><p style="margin-left:.5in">&nbsp;</p><table cellspacing="0" cellpadding="0" border="1"><tbody><tr><td style="vertical-align:top; width:467.5pt"><p>&bull; Saudi Arabia:</p><p>The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>&bull; Fax: +966-11-205-7662</p><p>&bull; Call NPC at +966-11-2038222, Exts: 2317-2356--2340.</p><p>&bull; Toll free phone: 19999</p><p>&bull; E-mail: npc.drug@sfda.gov.sa</p><p>&bull; Website: www.sfda.gov.sa/npc</p><p>&bull; Other GCC States:</p><p>Please contact the relevant competent authority.</p></td></tr></tbody></table><p style="margin-left:.5in">By reporting side effects, you can help provide more information on the safety of this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.<br />Do not store above 30 &deg;C.<br />Ringer&rsquo;s Lactate Infusion should NOT be given to you after the expiry date which is stated on the bag after EXP: MM/YYYY. The expiry date refers to the last day of that month.<br />You should not be given Ringer&rsquo;s Lactate Infusion, if there are particles floating in the solution or if the unit is damaged in any way.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What Ringer&rsquo;s Lactate Infusion contains<br />The active substances are:<br />- sodium chloride: 6.00 g per litre<br />- potassium chloride: 0.40 g per litre<br />- calcium chloride dihydrate: 0.27 g per litre<br />- sodium lactate: 3.20 g per litre.<br />The only other ingredient is water for injections.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Ringer’s Lactate Infusion looks like and contents of the pack
Ringer’s Lactate Infusion is a clear solution, free from visible particles. It is supplied in poly (vinyl chloride) co-extruded plastic bags (Viaflex). Each bag is wrapped in a sealed, protective, outer plastic overpouch.
The bag sizes are:
- 250 ml
- 500 ml
- 1000 ml
Pack sizes:
- 40 bags of 250 ml per carton
- 26 bags of 500 ml per carton
- 16 bags of 1000 ml per carton
Not all pack sizes may be marketed
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorisation Holder:<br />Baxter Company Limited<br />Dammam 2nd Industrial City,<br />Dammam 34334,<br />Saudi Arabia<br />Manufacturers:<br />Baxter Company Limited<br />Dammam 2nd Industrial City,<br />Dammam 34334,<br />Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                05/2018
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>&nbsp;</p><p>هو محلول يتكوّن من المواد التالية في المياه:<br />- كلوريد الصوديوم<br />- كلوريد البوتاسيوم<br />- ثنائي هيدرات كلوريد الكالسيوم<br />- لاكتات الصوديوم<br />الصوديوم، والبوتاسيوم، والكالسيوم، والكلوريد واللاكتات هي المواد الكيميائية (الشوارد) الموجودة في الدم.<br />يستخدم لاكتات الرينجر:<br />- لمعالجة نقص الجسم من المياه والمواد الكيميائية (على سبيل المثال عن طريق التعرّق الشديد، واضطرابات الكلى)<br />- لمعالجتك إذا كان حجم الدم في أوعيتك الدموية منخفضاً (نقص حجم الدم)، أو إذا كان ضغط الدم منخفض.<br />- في حالة الحماض الأيضي (عندما تكون نسبة الحمض في الدم مرتفعة جداً).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>لا تستخدم لاكتات الرينجر إذا كنت تعاني أيّاً من الحالات التالية<br />- إذا كان المريض حديث الولادة (أصغر من ٢٨ يوماً) ويتلقّى المضاد الحيوي سيفترياكسون.<br />.( - إذا كان لديك حساسية تجاه لاآتات الصوديوم أو أيّ مواد أخرى موجودة في لاكتات الرينجر(المدرجة في القسم ٦<br />- احتباس السوائل في المساحات التي تحيط بخلايا الجسم (فرط التعرّق خارج الخلية)<br />- زيادة حجم الدم في الأوعية الدموية عن المعدّل الطبيعي (فرط حجم الدم)<br />- فشل حادّ في وظيفة الكلى (عندما لا تؤدي الكلية وظيفتها جيداً ويُصبح هناك حاجة لغسل الكلى)<br />- فَشل القلب الغير معوض، أي فشل القلب الذي لم يتم علاجه بشكلٍ كافٍ ويسبّب الأعراض مثل:<br />- الضيق في التنفس<br />- تورّم الكاحلين<br />- ارتفاع مستوى البوتاسيوم في الدم أعلى من المعدّل الطبيعي (فرط البوتاسيوم في الدم)<br />- عندما يكون مستوى الكالسيوم في الدم أعلى من المعدّل الطبيعي (فرط الكالسيوم في الدم)</p><p>- اضطراب يصبح فيه الدم قلوياً جداً (القلاء الأيضي)<br />- التليف الكبدي الاستسقائي الذي يُسبّب احتباس السوائل في البطن<br />- يصبح دمك حمضياً جداً مما يشكل خطراً على حياتك (حماض أيضي حادّ)<br />- نوع معين من الحماض الأيضي (الحماض اللبني)<br />- مرض الكبد الحادّ (عندما لا يعمل الكبد بشكل صحيح ويتطلب علاجاً مكثفاً جداً)<br />- ضعف استقلاب اللاكتات (يحدث هذا في حالة مرض الكبد الحاد، فهو المسؤول عن التخلّص من اللاكتات)<br />- في حال تناول جليكوسيدات القلب (مقويات للقلب) المستخدمة لعلاج قصور القلب، مثل الديجيتال أو الديجوكسين.<br />(راجع أيضاً &quot;تناول أدوية أخرى&quot;)<br /><strong>تحذير واحتياطات</strong><br />أعلم الطبيب أو الممرّضة إذا كنت تعاني أو عانيت مسبقاً هذه الحالات المرضية قبل أن تبدأ باستخدام لاكتات الرينجر:<br />- إذا كنت تتناول المضاد الحيوي سيفترياكسون. (راجع أيضاً &quot;تناول أدوية أخرى و لاكتات الرينجر&quot;)<br />- نوبة قلبية<br />- فشل تنفّسي (داء الرئة) (قد تحتاج إلى مراقبة تحديداً في هذه الحالات المذكورة)<br />- ضعف في وظيفة الكليتين<br />- عندما يكون مستوى الكلوريد في الدم أعلى من المعدّل الطبيعي (زيادة الكلوريد في الدم)</p><p>- ارتفاع في ضغط الدم<br />- انتشار سائل تحت البشرة في جميع أنحاء الجسم (استسقاء عامّ)<br />- احتباس السوائل تحت البشرة، وتحديداً عند منطقة الكاحلين (وذمة محيطية)<br />- احتباس السوائل في الرئتين (وذمة رئوية)<br />- ارتفاع ضغط الدم أثناء الحمل (مقدمات الارتعاج)<br />- مرض يسبّب مستويات عالية من هرمون يُسمّى الألدوستيرون (الألدوستيرونية).<br />- عندما يكون مستوى الصوديوم في الدم أعلى من المعدّل الطبيعي، أو أي حالة أخرى مرتبطة باحتباس الصوديوم<br />(عندما يحتفظ الجسم بالكثير من الصوديوم)، مثل العلاج بالستيرويدات (أنظر قسم &quot;تناول أدوية أخرى&quot; أدناه).<br />- أيّ نوعٍ من أمراض القلب<br />- أيّ حالة تشير إلى تعرّضك لارتفاع مستوى البوتاسيوم في الدم (فرط البوتاسيوم في الدم)، مثل:<br />- الفشل الكلوي<br />- قصور قشرة الكظر (يؤثّر مرض الغدة الكظرية هذا على الهرمونات التي تتحكم في تركيز المواد الكيميائية في الجسم).<br />- جفاف الجسم الحادّ (جفاف حادّ، جراء القيء أو الإسهال مثلاً)<br />- تلف خلايا البشرة الخارجية بشكلٍ مفرط (كما يحصل عند التعرّض لحرق بالغ) ما يوجب مراقبة دقيقة لمستوى البوتاسيوم في دمك.<br />- الأمراض الناتجة عن نسب عالية من فيتامين د (مثل الساركويد، وهو مرض يؤثر على الجلد والأعضاء الداخلية)</p><p>- الحصاة الكلوية<br />- ضعف وظيفة الكبد<br />- السكري<br />إذا كان لديك حالة يمكن أن تسبب مستويات عالية من الفازوبرسين ، وهو هرمون منظم السؤائل في جسمك. قد يكون لديك الكثير من من الفازوبرسين في جسمك، على سبيل المثال:<br />- لقد كان لديك مرض مفاجئ وخطير<br />- لديك الم<br />- لقد أجريت لك عملية جراحية<br />- لديك عدوى أو حروق أو مرض في الدماغ<br />- لديك أمراض مرتبطة بالقلب أو الكبد أو الكلى أو الجهاز العصبي المركزي<br />- لأنك تتناول أدوية معينة (انظر أيضا أدناه أدوية أخرى و &quot;حقن رينجر لاكتات&quot;).<br />هذا قد يزيد من خطر انخفاض مستويات الصوديوم في الدم ويمكن أن يؤدي إلى الصداع والغثيان والنوبات والخمول والغيبوبة وتورم في المخ والوفاة. يزيد تورم الدماغ من خطر الوفاة وتلف الدماغ. الأشخاص الذين هم أكثر عرضة</p><p>لخطر تورم الدماغ هم:<br />- الأطفال<br />- النساء (خاصة إذا كنت من سن الخصوبة)<br />- الأشخاص الذين لديهم مشاكل مع مستويات سوائل الدماغ ، على سبيل المثال ، بسبب التهاب السحايا ، والنزيف في الجمجمة أو إصابة الدماغ.<br />عندما يتم إعطاؤك لاكتات الرينجر ، سيأخذ الطبيب عينات من الدم والبول لمراقبة:<br />- كمية المواد الكيميائية مثل الصوديوم والبوتاسيوم في الدم (شوارد البلازما في الدم)<br />- حموضة الدم والبول (التوازن الحمضي القاعدي)</p><p>على الرغم من أن لاكتات الرينجر يحتوي على البوتاسيوم، فإنهه لا يحتوي على ما يكفي لعلاج مستويات منخفضة جداً من البوتاسيوم في بلازما الدم (نقص البوتاسيوم الشديد).<br />يُمكن لكلوريد الكالسيوم أن يكون مؤذياً إذا تمّ حقنه من خلال أنسجة الجسم. لذلك لا يجب حقن محلول لاكتات الرينجر في العضلات (الحقن في العضل). يتّخذ الطبيب آافة الاحتياطات من أجل تجنّب أي تسريبٍ للمحلول إلى الخلايا المحيطة بالوريد.<br />لا يمكن حقن محلول لاكتات الرينجر بالإبرة نفسها التي تُستخدَم لنقل الدم. يمكن لذلك أن يتلف خلايا الدم الحمراء أو يتسبّب بتكتّلها.</p><p>يحتوي لاكتات الرينجر على اللاكتات، وهي مادة موجودة في الجسم، ما قد يؤدي إلى قلوية الدم بشكلٍ بالغ (قلاء استقلابي).<br />يجب وصف لاكتات الرينجر بدقّة تحديداً للأطفال الذين يقلّ عمرهم عن ٦ أشهر.<br />سيأخذ الطبيب في الاعتبار إذا آنت تتلقى التغذية بالحقن (التغذية عن طريق الحقن في الوريد). إذا أعطيت لاكتات الرينجر لمدّة طويلة، سيصف لك الطبيب مصدراً غذائياً إضافياً.</p><p><strong>تناول أدوية أخرى مع لاكتات الرينجر</strong><br />يجب إعلام الطبيب أو المُمرّضة إذا آنت تتناول أدوية أخرى، أو سبق أن تناولتها مؤخراً أو قد تتناولها قريباً.<br />من المهم جداً أن تبلغ الطبيب إذا آنت تتناول:<br />- مضاداً حيوياً يُسمى سيفترياكسون، ولا ينبغي إعطاؤه عبر الأنبوب نفسه إلّا في حال تمّ تنظيفه جيداً بالماء.<br />- غليكوسيدات القلب (مقويات للقلب) مثل الديجيتال أو الديجوكسين، التي تستخدم لعلاج قصور القلب إذ يجب ألا تستخدم مع محلول لاكتات الرينجر (راجع أيضاً قسم &quot;لا تستخدم محلول لاكتات الرينجر إذا كنت تعاني ...&quot;). قد تزيد آثار هذه الأدوية بفعل الكالسيوم، ما قد يؤدي إلى تغييرات تهدّد حياة المريض بسبب تغيّر ضربات القلب<br />- كورتيكوستيرويد (أدوية مضّادة للالتهاب)<br />يمكن أن تتسبّب هذه الأدوية في احتباس الصوديوم والماء في الجسم، ممّا يؤدّي إلى:<br />- تورّم الأنسجة بسبب احتباس السوائل تحت البشرة<br />- ارتفاع في ضغط الدم.<br />يُمكن للأدوية المذكورة تالياً أن تزيد من تركيز البوتاسيوم في الدم، الأمر الذي يشكّل تهديداً على حياة المريض. فقد يكون ارتفاع مستويات البوتاسيوم في الدم نتيجة لمرض الكلى.<br />- مدرّ البول الموفّر للبوتاسيوم (بعض أقراص المياه على مثال الأميلورايد، والسبيرونولاكتون وتريامتيرين)<br />(لاحظ أنّ هذه الأدوية قد تكون مندرجة في تركيبة منتجات طبية)</p><p>- مثبطات للإنزيم المحول للأنجيوتنسين (تُستخدم لعلاج ارتفاع ضغط الدم)<br />&nbsp;- مضادات مستقبلات للأنجيوتنسينII&nbsp; (تُستخدم لعلاج ارتفاع ضغط الدم)</p><p>- تاكروليموس (يستخدم لمنع رفض الأعضاء المزروعة وعلاج بعض الأمراض الجلدية)</p><p>- السيكلوسبورين (يستخدم لمنع رفض الأعضاء المزروعة)<br />بعض الأدوية التي تعمل على هرمون فازوبرسين. قد تشمل هذه:<br />- دواء مضاد للسكري (كلوربروباميد)<br />- دواء الكوليسترول (كلوفيرات)<br />- بعض أدوية السرطان (فينكريستين ، وإفوسفاميد ، وسيكلوفوسفاميد)<br />- مثبطات امتصاص السيروتونين الانتقائية (تستخدم لعلاج الاكتئاب)<br />- مضادات الذهان<br />- المواد الأفيونية لتخفيف الآلام الشديدة<br />- أدوية الألم و / أو الالتهاب (المعروف أيضًا باسم مضادات الالتهاب غير الستيروئيدية)<br />- الأدوية التي تقلد أو تقوي آثار فازوبريسين مثل ديسموبريسين (تستخدم لعلاج العطش المتزايد والتبول) ، ترليبريسين<br />(يستخدم لعلاج نزيف من المريء) والأوكسيتوسين (يستخدم للحث على المخاض)<br />- الأدوية المضادة للصرع (كاربامازيبين و أوكسكاربازبين)<br />- مدرات البول (أقراص الماء).</p><p>الأدوية الأخرى التي يمكن أن تؤثر أو تتأثر بلاكتات الرينجر هي:<br />- مدرات البول الثيازيدية مثل الهيدروكلوروثَيازيد أو الكلورتاليدون<br />- الفيتامين د<br />- البايفوسفونيت (لعلاج أمراض العظام مثل هشاشة العظام)<br />- الفلورايد (للأسنان والعظام)<br />- الفلوروكينولونات (نوع من المضادات الحيوية، بما في ذلك سيبروفلوكساسين، ونورفلوكساسين وأوفلوكساسين)<br />- التتراسيكلين (نوع من المضادات الحيوية، بما في ذلك التتراسيكلين)<br />- الأدوية الحمضية، بما فيها:<br />- الساليسيلات التي تُستخدم لعلاج الالتهاب (الأسبرين)<br />- الباربيتورات (أقراص النوم)<br />- الليثيوم (يُستخدم من أجل معالجة الأمراض النفسية)<br />- أدوية القلوية (الأساسية)، بما فيها:<br />- مقلدات الودي (الأدوية المحفّزة مثل الإيفيدرين والبسيدوإيفيدرين اللذين يُستخدمان في أدوية السعال والزّكام)<br />- محفّزات أخرى (مثل ديكستروأمفيتامين وفينلفورامين)</p><p><strong>لاكتات الرينجر مع الأكل والشرب</strong><br />يُفضّل أن تراجع الطبيب لمعرفة ما الذي يُسمح لك بتناوله أوشربه<br /><strong>الحمل والرضاعة الطبيعية</strong><br />إذا آنتِ حاملاً أو ترضّعين طبيعياً، أو تعتقدين أنك حامل أو تخططين لتحملي، اطلبي نصيحة الطبيب أو المُمرّضة قبل<br />أن تأخذي هذا الدواء. يُمكن استخدام لاآتات الرينجر بأمان خلال الحمل والرضاعة الطبيعية. سيقوم الطبيب بمراقبة<br />مستويات المواد الكيميائية في الدم ومقدار السوائل في جسمك.<br />يمكن للجنين أن يمتصّ الكالسيوم من خلال المشيمة، ومن خلال الرضاعة الطبيعية بعد الولادة.<br />ومع ذلك، إذا توجّب إضافة دواء آخر إلى المحلول الخاص بك للحقن أثناء الحمل أو الرضاعة الطبيعية، يجدر بك:<br />- مراجعة الطبيب<br />- قراءة نشرة المريض للدواء المُضاف.<br /><strong>القيادة واستخدام الآلات</strong><br />استشر الطبيب أو الصيدلي عن القيادة واستخدام الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><br />يعتمد هذا الأمر على العمر والوزن والحالة، وسبب استخدام لاكتات الرينجر. آما قد تتأثّر الكمية التي تُعطى لك بالعلاجات<br />التي تخضع لها.</p><p><strong>يجب ألّا يتم وصف لاكتات الرينجر لكَ إذا كان هناك جسيمات عائمة في المحلول أو إذا كان الكيس تالفاً بأي شكلٍ من الأشكال</strong><strong>.</strong><br />يتم إعطاء محلول لاكتات الرينجر عبر أنبوب بلاستيكي يلتصق بإبرة يتم إدخالها في الوريد. عادة ما يُستخدم الوريد في ذراعك عند الحقن. ومع ذلك، قد يستخدم الطبيب طريقة أخرى ليعطيك الدواء.<br /><strong>قبل وأثناء التسريب ، سيقوم الطبيب بمراقبة:</strong><br />- كمية السائل في جسمك<br />- حموضة الدم والبول<br />- كمية الإلكتروليتات في جسمك (خاصة الصوديوم ، في المرضى الذين يعانون من ارتفاع مستوى الفازوبريسين ، أو يتناولون أدوية أخرى تزيد من تأثير الفازوبريسين).<br />يجب التخلّص من كل محلولٍ لم يتم استخدامه. لا يجب استخدام لاكتات الرينجر من كيس سبق أن تمّ استخدامه جزئياً.</p><p><strong>في حال تمّ حقن نسبة من لاكتات الرينجر أعلى من المعدّل الطبيعي</strong><br />في حال تمّ حقن نسبة من لاكتات الرينجر فائضة عن المعدّل الطبيعي، أو تمّ حقن المحلول بسرعة، قد تظهر الأعراض التالية:<br />- الماء و/أو الصوديوم (الملح) الزائد مع احتباس السوائل في الأنسجة (وذمة) مما يتسبب في التورم نتيجة فرط نسبة<br />البوتاسيوم في الدم تحديداً لدى المرضى الذين يعانون فشلاً كلوياً، ما يتسبب بظهور الأعراض التالية:<br />- شعور بالنمل أو بالحكة في الذراعين والساقين (مذَل)<br />- ضعف العضل<br />- عدم القدرة على التحرّك<br />- عدم انتظام ضربات القلب<br />- إحصار القلب (نبض قلب بطيء جداً)<br />- سكتة قلبية (توقّف القلب؛ حالة تهدد الحياة المريض)<br />- الارتباك<br />- فرط الكالسيوم في الدم (عندما يكون مستوى الكالسيوم في الدم أعلى من المعدّل الطبيعي) يسبّب أعراضاً مثل:<br />- فقدان الشهية (فقدان الشهية العصابي)<br />- الشعور بالمرض (الغثيان)<br />- القيء<br />- الإمساك</p><p>- آلام في البطن<br />- الاضطرابات النفسية مثل التهيج أو الاكتئاب<br />- شرب الكثير من الماء (عطش شديد)<br />- التبول أكثر من المعتاد (غزارة البول)<br />- أمراض الكليتين بسبب تراكم الكالسيوم فيهما (نيفروكالسينوسيس)<br />- الحصاة الكلوية<br />- الغيبوبة (فقدان الوعي)<br />- طعم معدني في الفم<br />- الاحمرار (هبات ساخنة)<br />- توسع الأوعية الدموية في الجلد (توسع الأوعية المحيطية).<br />- فرط البوتاسيوم في الدم (عندما يكون مستوى البوتاسيوم في الدم أعلى من المعدّل الطبيعي) والقلاء الأيضي (عندما يصبح الدم قلوياً للغاية)، تحديداً لدى المرضى الذين يعانون فشلاً آلوياً مما يسبب ظهور أعراض مثل<br />- تقلّبات في المزاج<br />- التعب</p><p>- الضيق في التنفس<br />- تصلب العضلات<br />- ارتعاش العضلات<br />- تقلص العضلات.<br />إذا تطوّرت لديك أي من هذه الأعراض يجب أن تقوم بإبلاغ الطبيب فوراً. سيتم إيقاف الحقن ومنحك العلاج وفقاً للأعراض.<br />إذا أضيف دواء إلى لاكتات الرينجر قبل حدوث الحقن الزائد، فإنّ هذا الدواء قد يسبب أعراضاً أخرى. يجب أن تقرأ النشرة المرفقة بالدواء المُضاف حيث تتوفّر لائحة بالأعراض المُحتملة.<br />التوقف عن استخدام لاكتات الرينجر<br />يقرّر الطبيب وقت الانتهاء من أخذ لاكتات الرينجر.<br />إذا كانت لديك أيّ أسئلة عن كيفية استخدام هذا المُنتج فلا تتردّد في استشارة الطبيب أو المُمرّضة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل كل الأدوية، يمكن أن يسبب هذا الدواء آثاراً جانبية لبعض الأشخاص. إذا كان لديك أياً من الأعراض<br />التالية يجب أن تعلم الطبيب أو الممرضة على الفور.<br />قد تكون الأعراض التالية علامات تشير إلى حساسية خطيرة قاتلة تُسمى صدمة تأقيَّة:</p><ul><li dir="rtl" style="text-align:right">الشرى التي قد تكون متواجدة في جزء من الجسم أو منتشرة</li><li dir="rtl" style="text-align:right">الطفح الجلدي</li><li dir="rtl" style="text-align:right">احمرار الجلد (حُمامى)</li><li dir="rtl" style="text-align:right">الحُكاك</li><li dir="rtl" style="text-align:right">تورّم البشرة (وذمة وعائية)</li><li dir="rtl" style="text-align:right">السعال</li><li dir="rtl" style="text-align:right">تضييق الشعب الهوائية مما يسبب صعوبة في التنفس (تشنج قصبي)</li><li dir="rtl" style="text-align:right">ضربات قلب سريعة (عدم انتظام ضربات القلب)</li><li dir="rtl" style="text-align:right">نبض قلب بطيء (بطء القلب)</li><li dir="rtl" style="text-align:right">انخفاض ضغط الدم</li><li dir="rtl" style="text-align:right">عدم الشعور بالراحة عند منطقة الصدر أو شعور بألم في الصدر</li><li dir="rtl" style="text-align:right">القلق</li><li dir="rtl" style="text-align:right">الشعور بضيق في منطقة الصدر، فيصعب التنفس</li><li dir="rtl" style="text-align:right">الضيق في التنفس</li><li dir="ltr">التوهّج</li><li dir="ltr">تهيج الحلق-</li><li dir="ltr">شعور بالنمل أو بالحكة في الذراعين والساقين (مذَل) -</li><li dir="ltr">انخفاض الشعور في الفم (نقص الحس في الفم) -</li><li dir="ltr">طعم متغير (خلل) -</li><li dir="ltr">الحمى -</li><li dir="ltr">الغثيان -</li><li dir="ltr">الصداع -</li></ul><p>ارتفاع مستوى البوتاسيوم في الدم أعلى من المعدّل الطبيعي (فرط البوتاسيوم في الدم)<br />مستويات منخفضة من الصوديوم في الدم التي يمكن أن تحصل أثناء العلاج في المستشفيات (نقص صوديوم الدم المكتسب)<br />والاضطرابات العصبية ذات الصلة (اعتلال الدماغ الحاد بنقص صوديوم الدم). يمكن أن يؤدي نقص صوديوم الدم إلى حدوث<br />إصابات دماغية لا يمكن علاجها والوفاة بسبب الوذمة / التورم الدماغي (انظر أيضًا في القسم ٢ &quot;التحذيرات والاحتياطات&quot;).<br />ردود الفعل جراء تقنية إعطاء الدواء تأتي على شكل الأعراض التالية:</p><ul><li>ألم موضعي أو احمرار أو تورم في موقع الحقن</li><li>تهيّج والتهاب الوريد الذي تمّ حقن المحلول فيه (التهاب وريدي)، ممّا يسبب احمراراً، أو ألماً أو حرقاً وتورماً على طول الوريد.</li><li>الطفح أو الحكة من موقع الحقن</li></ul><p>تشمل الآثار الجانبية الأخرى مع منتجات مماثلة (محاليل أخرى تحتوي على لاكتات الصوديوم) ما يلي:<br />- أعراض أخرى من فرط الحساسية/ردود الفعل الناتجة عن الحقن: انسداد الأنف (احتقان الأنف)، والعطس، وتورم في الحلق مما يؤدي إلى صعوبة في التنفس (وذمة الحنجرة تسمى أيضاً وذمة كوينك)، تورم الجلد (الوذمة الوعائية)<br />- تغيّرات في تركيزات المواد الكيميائية في الدم (اضطرابات في الشوارد الكهربائية)<br />- زيادة حجم الدم في الأوعية الدموية عن المعدّل الطبيعي (فرط حجم الدم)<br />- نوبة هلع<br />- ردود الفعل الأخرى بسبب تقنية الحقن: العدوى المنتقلة عند منطقة الحقن، وتسرّب المحلول إلى الأنسجة حول الوريد.<br />يمكن لهذا الأمر أن يضرّ الأنسجة ويسبب ندبة ونمل في موقع الحقن<br />إذا تمت إضافة دواء إلى محلول الحقنة، قد يسبب الدواء المُضاف أيضاً آثاراً جانبية أخرى. تعتمد الآثار الجانبية هذه على الدواء الذي تمت إضافته. ينبغي أن تقرأ النشرة المرفقة بالدواء المُضاف حيث تتوفر قائمة بالأعراض المحتملة.</p><p><strong>الإبلاغ عن آثار جانبية</strong><br />إذا لاحظت أي أثارٍ جانبية، تحدّث إلى الطبيب أو الممرّض. يشمل ذلك أيّ آثار جانبية محتملة غير مندرجة ضمن هذه النشرة.<br />يمكنك أيضاً الإبلاغ عن الآثار الجانبية مباشرة عن طريق النظام الوطني للإبلاغ المذآور أدناه. يمكنك بهذه الطريقة أن<br />تساعد على تقديم المزيد من المعلومات عن سلامة استخدام هذا الدواء.</p><p>&nbsp;</p><p>&nbsp;</p><p dir="RTL" style="text-align:right">&nbsp;</p><table cellspacing="0" cellpadding="0" border="1"><tbody><tr><td style="vertical-align:top; width:260.75pt"><p style="margin-left:.5in; text-align:right"><strong>المملكة العربية السعودية</strong><strong> -</strong></p><p style="text-align:right">المركز الوطني للتيقظ و السلامة الدوائية</p><p dir="RTL" style="text-align:right">فاكس: 00966112057662</p><p dir="RTL" style="text-align:right">للأتصال بالإدارة التنفيذية للتيقظ وإدارة الأزمات هاتف : 009661120382222</p><p dir="RTL" style="text-align:right">تحويلة: 2317-2356-2340</p><p dir="RTL" style="text-align:right">الهاتف المجاني: 19999</p><p style="text-align:right">npc.drug@sfda.gov.sa : البريد الإلكتروني</p><p style="text-align:right">www.sfda.gov.sa/npc الموقع الإلكتروني:</p><p style="text-align:right"><strong>: </strong><strong>&nbsp;دول الخليج الأخرى</strong><strong>-</strong></p><p style="text-align:right">الرجاء الإتصال بالمؤسسات والهيئات الوطنية في كل دولة</p><p style="text-align:right">&nbsp;</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يُحفظ هذا الدواء بعيداً عن متناول الأطفال.<br />يحفظ في درجة حرارة لا تزيد عن ٣٠ درجة مئوية<br />لا يجب وصف لاآتات الرينجربعد انتهاء تاريخ الصلاحية المطبوع على الكيس (تاريخ الانتهاء: الشهر/السنة). يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من الشهر المذكور.</p><p>يجب ألّا يتم وصف لاكتات الرينجر لكَ إذا كان هناك جسيمات عائمة في المحلول أو إذا كانت الوحدة تالفة بأي شكلٍ من الأشكال.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">المواد الفعّالة:<br />- كلوريد الصوديوم: ٦٫٠٠ غ في الليتر الواحد<br />- كلوريد البوتاسيوم: ٠٫٤٠ غ في الليتر الواحد<br />- ثنائي هيدرات كلوريد الكالسيوم: ٠٫٢٧ غ في الليتر الواحد<br />- لاكتات الصوديوم: ٣٫٢٠ غ في الليتر الواحد<br />المكوّنات الأخرى هي:<br />- ماء للحقن</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">كيف يكون لاكتات الرينجر ومحتويات الكيس<br />يُعدّ لاكتات الرينجر محلولاً نقياً، خالياً من الجسيمات المرئية أكياس الفيافلكس مصنوع من البولي بلاستيك ( كلوريد الفينيل) ويُغلّف كلّ كيس بغلافٍ خارجي من البلاستيك مغلق ووقائي.<br />أحجام الأكياس تتسع ل:<br />٢٥٠ مل -<br />٥٠٠ مل -<br />١٠٠٠ مل -<br />الأكياس متوفّرة في علب من الكرتون. وتحتوي كلّ علبة كرتون على الكميّات التالية:<br />٤٠ كيساً حجم ٢٥٠ مل -<br />٢٦ كيساً حجم ٥٠٠ مل -<br />١٦ كيساً حجم ١٠٠٠ مل -<br />قد لا يكون جميع أحجام الأكياس مسوقة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">الشركة الحائزة على ترخيص للتسويق:<br />شركة باكستر المحدودة<br />المنطقة الصناعية الثانية طريق رقم ٢٠٤١<br />الدمام، المملكة العربية السعودية<br />الشركة المصنّعة:<br />شركة باكستر المحدودة<br />المنطقة الصناعية الثانية طريق رقم ٢٠٤١<br />الدمام، المملكة العربية السعودية</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            05/2018
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Ringer’s Lactate Solution for Intravenous Infusion in Viaflex
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sodium Chloride:                                                              6.00 g/l
Potassium Chloride:                                                        0.40 g/l
Calcium Chloride dihydrate:                                         0.27 g/l
Sodium Lactate:                                                              3.20 g/l
                                Na+         K+                   Ca++            Cl-              C3H5O3- (lactate)
mmol/l                 131              5                    2                 111                          29
mEq/l                   131             5                      4                 111                         29
For the full list of excipients, see section 6.1
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for infusion.
Clear solution, free from visible particles.
278 mOsm/l (approx.)
pH: 5.0 – 7.0
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ringer&rsquo;s Lactate solution is used in the following indications:</p><ul><li> Restoration of extracellular fluid and electrolytes balances or replacement of extracellular fluid loss where isotonic concentrations of electrolytes are sufficient</li><li> Short term volume replacement (alone or in association with colloid) in case of hypovolaemia or hypotension.</li><li> Regulation or maintenance of metabolic acidosis balance and/or treatment of mild to moderate metabolic acidosis (except lactic acidosis)</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u><br /><em><u>Adults, the Elderly and Children:</u></em></p><p>Fluid balance, serum electrolytes and acid-base balance should be monitored before and during administration, with particular attention to serum sodium in patients with increased non-osmotic vasopressin release (syndrome of inappropriate antidiuretic hormone secretion, SIADH) and in patients co-medicated with vasopressin agonist drugs, due to the risk of hospital acquired hyponatraemia (see sections 4.4, 4.5 and 4.8). Monitoring of serum sodium is particularly important for hypotonic fluids.</p><p>Ringer&rsquo;s Lactate solution has a tonicity of 278 mOsm/l (approx.)</p><p>The infusion rate and volume depend on the age, weight, clinical condition (e.g. burns, surgery, head-injury, infections), and concomitant therapy should be determined by the consulting physician experienced in intravenous fluid therapy (see sections 4.4. and 4.8).<br /><em>Recommended dosage:</em><br />The amount of Ringer&rsquo;s Lactate solution needed to restore normal blood volume is 3 to 5 times the volume of lost blood.<br />The recommended dosage is:<br />- for adults: 500 ml to 3 L/24h<br />- for infants, toddlers and children: 20 ml to 100 ml/kg/24 h<br /><em>Administration rate:</em><br />The infusion rate is usually 40 mL/kg/24h in adults.<br /><em>Use in paediatric patients</em><br />The safety and efficacy of Ringer&rsquo;s Lactate solution in children has not been established by adequate and well-controlled trials; however, the use of electrolyte solutions in the paediatric population is referenced in the medical literature. Lactate-containing solutions should be administered with particular caution to neonates and infants less than 6 months of age.</p><p>Paediatric infusion rates is 5 ml/kg/h in average but the value varies with age:<br />&bull; infants: 6-8 mL/kg/h,<br />&bull; toddlers: 4-6 mL/kg/h<br />&bull; children: 2-4 mL/kg/h .<br />In children with burns, the dose is on average 3.4 mL/kg/per cent burn at 24 h post-burn and 6.3 mL/kg/per cent burn at 48 h.<br />In severely head-injured children the dose is on average 2850 mL/m&sup2;.<br />Infusion rate and total volume can be higher in surgery or in case of need.<br />Note:<br />- infants and toddlers: aged from 28 days to 23 months (a toddler is an infant who can walk)<br />- children: age from 2 to 11 years<br /><em>Use in geriatric patients</em><br />When selecting the type of infusion solution and the volume/rate of infusion for a geriatric patient, consider that geriatric patients are generally more likely to have cardiac, renal, hepatic, and other diseases or concomitant drug therapy.<br /><u>Method of administration:</u><br />The solution is for intravenous administration through a sterile and non-pyrogenic administration set using aseptic technique. The equipment should be primed with the solution in order to prevent air entering the system.<br />The solution should be inspected visually for particulate matter and discoloration prior to administration. Do not administer unless the solution is clear, free from visible particlesand the seal is intact. Do not remove unit from overwrap until ready for use. The inner bagmaintains the sterility of the solution. Administer immediately following the insertion of infusion set.</p><p>Do not connect flexible plastic containers in series in order to avoid air embolism due to possible residual air contained in the primary container. Pressurizing intravenous solutions contained in flexible plastic containers to increase flow rates can result in air embolism if the residual air in the container is<br />not fully evacuated prior to administration. Use of a vented intravenous administration set with the vent in the open position could result in air embolism. Vented intravenous administration sets with the vent in the open position should not be used with flexible plastic containers.<br />Additives may be introduced before infusion or during infusion through the injection site. When making additions to Ringer&rsquo;s Lactate solution, aseptic technique must be used. Mix the solution thoroughly when additives have been introduced. Do not store solutions containing additives.<br />For information on incompatibilities and preparation of the product with additives, please see sections 6.2 and 6.6.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                As for other calcium-containing infusion solutions, concomitant administration of ceftriaxone and Ringer’s Lactate solution is contraindicated in newborns (≤28 days of age), even if separate infusion lines are used (risk of fatal ceftriaxone-calcium salt precipitation in the neonate’s bloodstream). For patients over 28 days of age please see section 4.4.
Ringer’s Lactate solution is also contraindicated in patients with
• A known hypersensitivity to sodium lactate.
• Extracellular hyperhydration or hypervolaemia
• Severe renal insufficiency (with oliguria/anuria)
• Uncompensated cardiac failure
• Hyperkalaemia
• Hypercalcaemia
• Metabolic alkalosis
• Ascitic cirrhosis
• Severe metabolic acidosis
• Conditions associated with increased lactate levels (hyperlactataemia) including lactic acidosis, or impaired lactate utilization, such as severe hepatic insufficiency.
• Concomitant digitalis therapy (see section 4.5 Interactions with other medicinal products and other forms of interaction)
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Hypersensitivity reactions</strong><br />The infusion must be stopped immediately if any signs or symptoms of a suspected hypersensitivity reaction develop. Appropriate therapeutic countermeasures must be instituted as clinically indicated.</p><p><strong>Incompatibilities</strong><br /><em>Ceftriaxone</em><br />In patients older than 28 days (including adults), ceftriaxone must not be administered simultaneously with intravenous calcium-containing solutions, including Ringer&rsquo;s Lactate solution, through the same infusion line. If the same infusion line is used for sequential administration, the line must be thoroughly flushed between infusions with a compatible fluid. For patients under 28 days please see section 4.3.<br /><strong>Electrolyte balance</strong><br /><em>Hypernatraemia</em><br />Ringer&rsquo;s Lactate solution should only be administered to patients with hypernatraemia after careful consideration of the underlying cause and alternative intravenous fluids. Monitoring of plasma sodium and volume status during treatment is recommended.<br />Ringer&rsquo;s Lactate solution should be administered with particular caution in patients with conditions predisposing to hypernatraemia (such as adrenocortical insufficiency, diabetes insipidus or extensive tissue injury) and in patients with cardiac disease.<br /><em>Hyperchloraemia</em><br />Ringer&rsquo;s Lactate solution should only be administered to patients with hyperchloraemia after careful consideration of the underlying cause and alternative intravenous fluids. Monitoring of plasma chloride and acid-base balance during treatment is recommended.<br />Ringer&rsquo;s Lactate solution should be administered with particular caution to patients with conditions predisposing to hyperchloraemia (such as renal failure and renal tubular acidosis, diabetes insipidus), and patients with urinary diversion or patients taking certain diuretics (carbonic anhydrase inhibitors eg acetazolamide) or steroids (androgens, estrogens corticosteroids) and in patients with severe dehydration.</p><p><em>Use in patients with potassium deficiency</em><br />Although Ringer&rsquo;s Lactate solution has a potassium concentration similar to the concentration in plasma, it is insufficient to produce a useful effect in case of severe potassium insufficiency and therefore it should not be used for this purpose.<br /><em>Use in patients at risk for hyperkalaemia</em><br />Ringer&rsquo;s Lactate solution should be administered with particular caution to patients with conditions predisposing to hyperkalaemia (such as severe renal impairment or adrenocortical insufficiency, acute dehydration, or extensive tissue injury or burns) and in patients with cardiac disease. The plasma potassium level of the patient must be particularly closely monitored in patients at risk of hyperkalaemia.<br /><em>Use in patients at risk for hypercalcaemia</em><br />Calcium chloride is irritant, therefore care should be taken to prevent extravasation during intravenous injection and intramuscular injection must be avoided. Solutions containing calcium salts should be used with caution in patients with conditions predisposing to hypercalcaemia, such as patients with renal impairment and granulomatous diseases associated with increased calcitriol synthesis such as sarcoidosis, calcium renal calculi or a history of such calculi.</p><p><strong>Fluid balance/renal function</strong><br /><em>Use in patients with renal impairment</em><br />Ringer&rsquo;s Lactate solution should be administered with particular caution to patients with renal impairment. In such patients administration of Ringer&rsquo;s Lactate solution may result in sodium and/or potassium retention.<br /><em>Risk of Fluid and/or Solute Overload and Electrolyte Disturbances</em><br />Depending on the volume and rate of infusion, intravenous administration of Ringer&rsquo;s Lactate solution can cause<br />&bull; fluid and/or solute overload resulting in overhydration and, for example, congested states, including pulmonary congestion and oedema.<br />&bull; clinically relevant electrolyte disturbances and acid-base imbalance.<br />Clinical evaluation and periodic laboratory determinations may be necessary to monitor changes in fluid balance, electrolyte concentrations and acid-base balance during prolonged parenteral therapy or whenever the condition of the patient or the rate of administration warrants such evaluation.<br />High volume infusion must be used under specific monitoring in patients with cardiac or pulmonary failure and in patients with non-osmotic vasopressin release (including SIADH), due to the risk of hospital-acquired hyponatraemia (see below).<br /><em>Hyponatraemia</em><br />Patients with non-osmotic vasopressin release (e.g. in acute illness, pain, post-operative stress, infections, burns, and CNS diseases), patients with heart-, liver- and kidney diseases and patients exposed to vasopressin agonists (see section 4.5) are at particular risk of acute hyponatraemia upon infusion of hypotonic fluids.</p><p>Acute hyponatraemia can lead to acute hyponatraemic encephalopathy (cerebral oedema) characterized by headache, nausea, seizures, lethargy and vomiting. Patients with cerebral oedema are at particular risk of severe, irreversible and life-threatening brain injury.<br />Children, women in the fertile age and patients with reduced cerebral compliance (e.g. meningitis, intracranial bleeding, cerebral contusion and brain oedema) are at particular risk of the severe and life-threatening brain swelling caused by acute hyponatraemia.<br /><em>Use in patients with hypervolaemia, overhydration or conditions causing sodium retention and oedema</em><br />Ringer&rsquo;s Lactate solution should be administered with particular caution to hypervolaemic or overhydrated patients.<br />Due to the sodium chloride content Ringer&rsquo;s Lactate solution, should be administered with particular caution to patients with conditions that may cause sodium retention, fluid overload and oedema, such as patients with primary hyperaldosteronism, secondary hyperaldosteronism (associated with, e.g., hypertension, congestive heart failure, renal artery stenosis, or nephrosclerosis), or preeclampsia. (see also Section 4.5)<br /><strong>Acid-base balance</strong><br /><em>Use in patients at risk for alkalosis</em></p><p>Ringer&rsquo;s Lactate solution should be administered with particular caution to patients at risk for alkalosis. Because lactate is metabolized to bicarbonate, administration may result in, or worsen, metabolic alkalosis. Seizure may be precipitated by the alkalosis induced by lactate but this is uncommon.<br /><strong>Other warnings</strong><br /><em>Administration of citrate anticoagulated/preserved blood</em><br />Due to the risk of coagulation precipitated by its calcium content, Ringer&rsquo;s Lactate solution must not be added to or administered simultaneously through the same tubing with citrate anticoagulated/preserved blood.<br /><em>Use in patients with type 2 diabetes</em><br />Lactate is a substrate for gluconeogenesis. Therefore, glucose levels should be carefully monitored in patients receiving Ringer&rsquo;s Lactate.<br /><em>Administration</em><br />Adding other medication or using an incorrect administration technique might cause the appearance of fever reactions due to the possible introduction of pyrogens. In such case the infusion must be stopped immediately.<br />For information on incompatibilities and preparation of the product with additives, please see sections 6.2 and 6.6.<br />During long term, parenteral treatment, a convenient nutritive supply must be given to the patient.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Ceftriaxone</em>: See sections 4.3 and 4.4 for more information<br /><em>Drugs leading to an increased vasopressin effect</em><br />The below listed drugs increase the vasopressin effect, leading to reduced renal electrolyte free water excretion and may increase the risk of hospital acquired hyponatraemia following inappropriately balanced treatment with i.v. fluids (see sections 4.2, 4.4 and 4.8).<br />&bull; Drugs stimulating vasopressin release include: Chlorpropamide, clofibrate, carbamazepine, vincristine, selective serotonin reuptake inhibitors, 3.4-methylenedioxy-N-methamphetamine, ifosfamide, antipsychotics, narcotics<br />&bull; Drugs potentiating vasopressin action include: Chlorpropamide, NSAIDs, cyclophosphamide<br />&bull; Vasopressin analogues include: Desmopressin, oxytocin, terlipressin<br />Other medicinal products increasing the risk of hyponatraemia also include diuretics in general and antiepileptics such as oxcarbazepine.<br /><em>Interaction related to the presence of sodium:</em><br />Caution is advised when administering Ringer&rsquo;s Lactate solution to patients treated with drugs that may increase the risk of sodium and fluid retention (with oedema and hypertension), such as corticosteroids.</p><p><em>Interaction related to the presence of potassium:</em><br />Because of its potassium content, Ringer&rsquo;s Lactate solution should be administered with caution in patients treated with agents or products that can cause hyperkalaemia or increase the risk of hyperkalaemia, such as<br />- Potassium-sparing diuretics (amiloride, spironolactone, triamterene, alone or in association).<br />- Angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor antagonists<br />- Tacrolimus, cyclosporine<br />Administration of potassium in patients treated with such medications can produce severe and potentially fatal hyperkalaemia, particularly in patients with severe renal insufficiency.<br /><em>Interaction related to the presence of calcium:</em><br />Administration of calcium may increase the effects of digitalis and lead to serious or fatal cardiac arrhythmia. Therefore, larger volumes or a faster infusion rates should be used with caution in patients treated with digitalis glycosides.<br />- Caution is advised when administering Ringer&rsquo;s Lactate solution to patients treated with thiazide diuretics or vitamin D, as these can increase the risk of hypercalcaemia.<br />- Bisphosphonates, fluoride, some fluoroquinolones and tetracyclines which are less absorbed (lower availability) when administered with calcium.</p><p><em>Interaction related to the presence of lactate (which is metabolized into bicarbonate):</em><br />Caution is advised when administering Ringer&rsquo;s Lactate solution to patients treated with drugs for which renal elimination is pH dependent. Due to the alkalinizing action of lactate (formation of bicarbonate), Ringer&rsquo;s Lactate solution may interfere with the elimination of such drugs.<br />- Renal clearance of acidic drugs such as salicylates, barbiturates, and lithium may be increased because of the alkalinisation of urine by the bicarbonate resulting from lactate metabolism.<br />- Renal clearance of alkaline drugs, such as sympathomimetics (e.g. ephedrine, pseudoephedrine) and stimulants (e.g. dexamphetamine sulfate, phenfluramine hydrochloride) may be decreased</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ringer&rsquo;s Lactate solution can be used safely during pregnancy and lactation as long as the electrolyte- and fluid balance is controlled.<br />It is reminded that calcium crosses the placenta and is distributed into breast milk.<br />Ringer&rsquo;s Lactate solution should be administrated with special caution for pregnant women during labour particularly as to serum-sodium if administered in combination with oxytocin (see section 4.4, 4.5 and 4.8).</p><p>When a medication is added, the nature of the drug and its use during pregnancy and lactation have to be considered separately.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is no information of the effects of Ringer&rsquo;s Lactate solution on the ability to operate an automobile or other heavy machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following adverse reactions (listed by MedDRA System Organ Class) have been reported spontaneously during the post-market experience.</p><p>&nbsp;</p><table cellspacing="0" cellpadding="0" border="1"><tbody><tr><td style="vertical-align:top; width:233.75pt"><p>Immune System Disorders</p></td><td style="vertical-align:top; width:233.75pt"><p>Hypersensitivity/Infusion reactions including Anaphylactic/Anaphylactoid reaction, possibly manifested by one or more of the following symptoms: Angioedema, Chest pain, Chest discomfort, Decreased heart rate, Tachycardia, Blood pressure decreased, Respiratory distress, Bronchospasm, Dyspnea, Cough, Urticaria, Rash, Pruritus, Erythema, Flushing, Throat irritation, Paresthesias, Hypoesthesia oral, Dysgeusia, Nausea, Anxiety, Pyrexia, Headache</p></td></tr><tr><td style="vertical-align:top; width:233.75pt"><p>Metabolism and Nutrition Disorders</p></td><td style="vertical-align:top; width:233.75pt"><p>Hyperkalaemia</p><p>Hospital acquired hyponatraemia*</p></td></tr><tr><td style="vertical-align:top; width:233.75pt"><p>Nervous system disorders</p></td><td style="vertical-align:top; width:233.75pt"><p>Acute hyponatraemic encephalopathy*</p></td></tr><tr><td style="vertical-align:top; width:233.75pt"><p>General Disorders and Administration Site Conditions</p></td><td style="vertical-align:top; width:233.75pt"><p>Infusion Site Reactions manifested by one or more of the following symptoms: Phlebitis, Infusion site inflammation, Infusion site swelling, Infusion site rash, Infusion site pruritus, Infusion site erythema, Infusion site pain, Infusion site burning</p></td></tr></tbody></table><p>*Hospital acquired hyponatraemia may cause irreversible brain injury and death, due to development of acute hyponatraemic encephalopathy, frequency unknown (see sections 4.2. 4.4, 4.5).</p><p>The following adverse reactions have been reported spontaneously during the use of other sodium-lactate containing solutions:</p><p style="margin-left:0in; margin-right:0in; text-indent:0in"><!--[if !supportLists]-->&nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp; <!--[endif]-->&bull; Hypersensitivity: Laryngeal oedema (Quincke&rsquo;s oedema), skin swelling, Nasal congestion, Sneezing</p><p style="margin-left:0in; margin-right:0in; text-indent:0in"><!--[if !supportLists]-->&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->&bull; Electrolyte disturbances</p><p style="margin-left:0in; text-indent:0in"><!--[if !supportLists]-->&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->&bull; Hypervolaemia</p><p style="margin-left:0in; margin-right:0in; text-indent:0in"><!--[if !supportLists]-->&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->&bull; Panic Attack</p><p style="margin-left:0in; text-indent:0in"><!--[if !supportLists]-->&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->&bull; Other infusion site reactions: Infection at the site of injection, Extravasation, Infusion site&nbsp; anesthesia (numbness)</p><p>Reporting of suspected adverse reactions</p><p>If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in this leaflet. Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via.</p><table cellspacing="0" cellpadding="0" border="1"><tbody><tr><td style="vertical-align:top; width:467.5pt"><p>&bull; Saudi Arabia:</p><p>The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>&bull; Fax: +966-11-205-7662</p><p>&bull; Call NPC at +966-11-2038222, Exts: 2317-2356--2340.</p><p>&bull; Toll free phone: 19999</p><p>&bull; E-mail: npc.drug@sfda.gov.sa</p><p>&bull; Website: www.sfda.gov.sa/npc</p><p>&bull; Other GCC States:</p><p>Please contact the relevant competent authority.</p><p>&nbsp;</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>An excessive volume or too high a rate of administration of Ringer&rsquo;s Lactate solution may lead to fluid and sodium overload with a risk of oedema (peripheral and/or pulmonary), particularly when renal sodium excretion is impaired. In this case extra renal dialysis may be necessary.<br />Excessive administration of potassium may lead to the development of hyperkalaemia, especially in patients with renal impairment. Symptoms include paresthesia of the extremities, muscle weakness, paralysis, cardiac arrhythmias, heart block, cardiac arrest, and mental confusion.<br />Excessive administration of calcium salts may lead to hypercalcaemia. Symptoms of hypercalcaemia may include anorexia, nausea, vomiting, constipation, abdominal pain, muscle weakness, mental disturbances, polydipsia, polyuria, nephrocalcinosis, renal calculi, and, in severe cases, cardiac arrhythmias and coma. Too rapid intravenous injection of calcium salts may also lead to many of the symptoms of hypercalcaemia as well as to chalky taste, hot flushes, and peripheral vasodilatation. Mild asymptomatic hypercalcaemia will usually resolve on stopping administration of calcium and other contributory drugs such as vitamin D. If hypercalcaemia is severe, urgent treatment (such as loop diuretics, haemodialysis, calcitonin, bisphosphonates, trisodium edetate) is required.<br />Excessive administration of lactate may lead to metabolic alkalosis. Metabolic alkalosis may be accompanied by hypokalaemia, Symptoms may include mood changes, tiredness, shortness of breath, muscle weakness, and irregular heartbeat. Muscle hypertonicity, twitching, and tetany may develop especially in hypocalcaemic patients. Treatment of metabolic alkalosis due to bicarbonate overdose consists mainly of appropriate correction of fluid and electrolyte balance. Replacement of calcium, chloride, and potassium may be of particular importance.</p><p>When overdose is related to medications added to the solution infused, the signs and symptoms of over infusion will be related to the nature of the additive being used. In the event of accidental over infusion, treatment should be discontinued and the patient should be observed for the appropriate signs and symptoms related to the drug administered. The relevant symptomatic and supportive measures should be provided as necessary.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group (ATC code): B05BB01 &ldquo;Electrolytes&rdquo;<br />Ringer&rsquo;s Lactate solution is an isotonic solution of electrolytes. The constituents of Ringer&rsquo;s Lactate Solution and their concentrations are designed to match those of plasma.<br />The pharmacological properties of the Ringer&rsquo;s Lactate solution are those of its components (sodium, potassium, calcium, chloride and lactate). The main effect of Ringer&rsquo;s Lactate Solution is the expansion of the extracellular compartment including both the interstitial fluid and the intravascular fluid.<br />The lactate is metabolised into bicarbonate, mainly in the liver, and produces an alkalinising effect on the plasma<br />In healthy volunteers receiving Ringer&rsquo;s Lactate Solution, central venous pressure changes were associated with a secretion of atrial natriuretic peptide<br />In healthy volunteers, Ringer&rsquo;s Lactate Solution decreased serum osmolality, increased blood pH, and the time until first urination was shorter than that with normal saline.<br />There is no significant change in glucagon, norepinephrine, epinephrine, blood glucose and insulin levels in aortic surgery patients receiving Ringer&rsquo;s Lactate Solution.<br />When medication is added to Ringer&rsquo;s Lactate Solution, the overall pharmacodynamics of the solution will depend on the nature of the drug used.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The pharmacokinetic properties of the Ringer&rsquo;s Lactate solution are those of the ions its composition includes (sodium, potassium, calcium and chloride).<br />Infusion of Ringer&rsquo;s Lactate Solution in normal hemodynamically stable adults does not increase circulating lactate concentrations.<br />The pharmacokinetics of D-lactate and L-lactate are similar. The lactate in Ringer&rsquo;s Lactate solution is metabolized by both oxidation and gluconeogenesis, predominantly in the liver, and bicarbonate is generated by both processes over 1-2 h.<br />When medication is added to Ringer&rsquo;s Lactate Solution, the overall pharmacokinetics of the solution will depend on the nature of the drug used.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical safety data of Ringer&rsquo;s Lactate Solution in animals are not relevant since its constituents are physiological components in animal and human plasma.<br />Toxic effects are not to be expected under the condition of clinical application.<br />The safety of potential additives should be considered separately</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Water for Injections<br />Sodium hydroxide<br />Lactic acid</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ceftriaxone must not be mixed with calcium-containing solutions including Ringer&rsquo;s Lactate solution. See also sections 4.3 and 4.4.<br />As with all parenteral solutions additives may be incompatible. Compatibility of the additives with the Ringer&rsquo;s Lactate solution and Viaflex container must be assessed before addition. After addition of the additive, incompatibility may become visible by a possible colour change and/or the appearance of precipitates, insoluble complexes or crystals.<br />The Instructions for Use of the medication to be added and other relevant literature must be consulted.<br />Before adding a substance or medication, verify that it is soluble and/or stable in water and that the pH range of Ringer&rsquo;s Lactate solution is appropriate (pH 5.0 to 7.0).<br />When making additions to Ringer&rsquo;s Lactate solution, aseptic technique must be used. Mix the solution thoroughly when additives have been introduced. Do not store solutions containing additives.</p><p>As a guidance the following medications are incompatible with the Ringer&rsquo;s Lactate solution (non-exhaustive listing):<br />Medications incompatible with Ringer&rsquo;s Lactate Solution</p><ul><li>Aminocaproic acid</li><li>Amphotericin B</li><li>Metaraminol tartrate</li><li>Cefamandole</li><li>Ceftriaxone</li><li>Cortisone acetate</li><li>Diethylstilbestrol</li><li>Etamivan</li><li>Ethyl alcohol</li><li>Phosphate and carbonate solutions</li><li>Oxytetracycline</li><li>Thiopental sodium</li><li>Versenate disodium</li></ul><p>Medications with partial incompatibility with Ringer&rsquo;s Lactate Solution:<br />Tetracycline stable for 12 hours<br />Ampicillin sodium<br />concentration of 2%-3% stable for 4 hours</p><p>concentration &gt;3% must be given within 1 hour<br />Minocycline stable for 12 hours<br />Doxycycline stable for 6 hours<br />Additives known or determined to be incompatible should not be used.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Shelf life (Unopened): 2 years for the1000 ml and 500 ml container
18 months for the 250 ml
In-use shelf-life: Additives
Chemical and Physical stability of any additive at the pH of Compound Sodium Lactate solution in the Viaflex container should be established prior to use.
From a microbiological point of view, the diluted product must be used immediately unless dilution has taken place in controlled and validated aseptic conditions. If not used immediately, in-use storage times and conditions are the responsibility of the user.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The bags known as Viaflex are composed of poly (vinyl chloride) co-extruded plastic.<br />Bag sizes: 250ml, 500ml and 1000ml.<br />The bags are overwrapped with a protective plastic pouch composed of poly (vinyl chloride)<br />Pack sizes:</p><ul><li>- 40 bags of 250 ml per carton</li><li>- 26 bags of 500 ml per carton</li><li>- 16 bags of 1000 ml per carton</li></ul><p>Not all pack sizes may be marketed</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>After opening the container, the contents should be used immediately and should not be stored for a subsequent infusion.<br />Discard after single use.<br />Discard any unused portion.<br />Do not reconnect partially used bags.</p><p><u>Opening</u></p><ul><li>&bull; Remove the Viaflex container from the overpouch just before use.</li><li>&bull; Check for minute leaks by squeezing inner bag firmly. If leaks are found, discard solution, as sterility may be impaired</li><li>&bull; Check the solution for clarity and absence of foreign matter. If solution is not clear or contains foreign matter, discard the solution.</li></ul><p><u>Preparation for administration</u><br />Use sterile material for preparation and administration.<br />&bull; Suspend container from eyelet support.<br />Remove plastic protector from outlet port at bottom of container:</p><ul><li>o grip the small wing on the neck of the port with one hand</li><li>o grip the large wing on the cap with the other hand and twist,</li><li>o the cap will pop off.</li></ul><p>&bull; Use an aseptic method to set up the infusion.<br />&bull; Attach administration set. Refer to directions accompanying set for connection, priming of the set and administration of the solution.</p><p><u>Techniques for injection of additive medications</u><br />Warning: Some additives may be incompatible. Check additive compatibility with both the solution and container prior to use. When additive is used, verify isotonicity prior to parenteral administration. Thorough and careful aseptic mixing of any additive is mandatory. Solutions containing additives should be used immediately and not stored.<br /><em>To add medication before administration</em></p><ul><li>&bull; Disinfect medication site.</li><li>&bull; Using syringe with 19 gauge (1.10 mm) to 22 gauge (0.70 mm) needle, puncture resealable medication port and inject.</li><li>&bull; Mix solution and medication thoroughly. For high-density medication such as potassium chloride, tap the ports gently while ports are upright and mix.</li></ul><p>Caution: Do not store bags containing added medications.<br /><em>To add medication during administration</em></p><ul><li>&bull; Close clamp on the set</li><li>&bull; Disinfect medication site.</li><li>&bull; Using syringe with 19 gauge (1.10 mm) to 22 gauge (0.70 mm) needle, puncture resealable medication port and inject.</li><li>&bull; Remove container from IV pole and/or turn to an upright position.</li><li>&bull; Evacuate both ports by tapping gently while the container is in an upright position.</li><li>&bull; Mix solution and medication thoroughly.</li><li>&bull; Return container to in use position, re-open the clamp and continue administration.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Baxter Co. Ltd.
Dammam, Saudi Arabia
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                November 2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>